Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd (GAUDIUMIVF) last traded at ₹116, a market capitalisation of ₹844 crore, on a P/E of 36.5. Over the past 52 weeks the stock has ranged between ₹69.2 and ₹164. Gaudium IVF and Women Health Ltd last reported results for the quarter ended Jun 2026, with sales of ₹19.38 crore and net profit of ₹1.78 crore. Gaudium IVF and Women Health Ltd’s annual general meeting is scheduled for 28 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Gaudium IVF and Women Health Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Gaudium IVF and Women Health Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹19.38 cr, up 9.1% from ₹17.76 cr a year earlier. Net profit was ₹1.78 cr, down 42.0% year on year.
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 14.42 | 26.92 | 17.76 | 31.73 | 24.51 | 30.35 | 19.38 |
| Expenses | 8.76 | 18.2 | 12.61 | 17.96 | 17.95 | 18.18 | 16.95 |
| Operating profit | 5.66 | 8.72 | 5.15 | 13.77 | 6.56 | 12.17 | 2.43 |
| OPM % | 39.25% | 32.39% | 29.00% | 43.40% | 26.76% | 40.10% | 12.54% |
| Other income | 0 | 0.23 | 0 | 0.15 | 0.1 | 0.18 | 1.12 |
| Interest | 0.39 | 0.43 | 0.5 | 0.51 | 1.2 | 1.29 | 0.38 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.61 | 0.49 | 0.64 | 0.72 |
| Profit before tax | 4.69 | 8.16 | 4.04 | 12.8 | 4.97 | 10.42 | 2.45 |
| Tax % | 27.72% | 20.96% | 24.01% | 26.64% | 26.96% | 19.77% | 27.76% |
| Net profit | 3.4 | 6.46 | 3.07 | 9.38 | 3.63 | 8.36 | 1.78 |
| EPS (₹) | 0.55 | 1.05 | 0.50 | 1.53 | 0.59 | 1.15 | 0.24 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Gaudium IVF and Women Health Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 37 | 44 | 48 | 71 | 104 | 106 |
| Operating profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37% | 46% | 41% | 41% | 36% | 33% |
| Net profit | 9 | 14 | 10 | 19 | 24 | 23 |
| EPS (₹) | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 | 3.51 |
TTM is the trailing twelve months to the most recent quarter.
Gaudium IVF and Women Health Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 33%
- TTM
- 48%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 22%
- TTM
- 28%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 41%
- 3 Years
- 34%
- Last Year
- 25%
Gaudium IVF and Women Health Ltd shareholding pattern
Promoters held 71.29% at Jun 2026, broadly unchanged since Mar 2026. FIIs 3.01% and DIIs 2.22%.
| % held | Mar 2026 | Jun 2026 |
|---|---|---|
| Promoters | 71.29% | 71.29% |
| FIIs | 6.70% | 3.01% |
| DIIs | 2.63% | 2.22% |
| Public | 19.39% | 23.47% |
| No. of shareholders | 19,854 | 21,910 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Gaudium IVF and Women Health Ltd
When is Gaudium IVF and Women Health Ltd’s AGM?
Gaudium IVF and Women Health Ltd’s annual general meeting is scheduled for 28 Sept 2026.
- AGM11th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Gaudium IVF and Women Health Ltd corporate filings
- Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Resullts for the quarter ended June 30, 2026.Company Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 revenue of 19.4 crore, a 9.1% YoY…
Read the full analysis - Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has formally disclosed the availability of the audio…
Read the full analysis - Newspaper publication of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has formally published its unaudited standalone and…
Read the full analysis - Revised Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026Company Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has released a revised investor presentation for the…
Read the full analysis - Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026.Company Updatehigh impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 consolidated revenue of 19.38…
Read the full analysis - Monitoring Agency Report for the quarter ended June 30, 2026.Company Updatelow impact
Cruxal's analysis: The company has submitted its Monitoring Agency Report for the quarter ended June 30…
Read the full analysis - Press Release on the Unaudited Financial Results of the Compony for the quater ended June 30, 2026.Company Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 revenue of 19.4 crore, a 9.13% YoY…
Read the full analysis - Intimation of Statement of Deviation & Variation of Funds for the quater ended June 30, 2026Company Updatelow impact
Cruxal's analysis: The company has submitted its Statement of Deviation or Variation regarding the…
Read the full analysis - Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026Board Meetingmedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 consolidated revenue of 19.38 crore…
Read the full analysis - Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has announced an earnings conference call to discuss its…
Read the full analysis - Gaudium IVF And Women Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Un-audited ....Board Meetinglow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has issued a formal intimation regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Gaudium IVF and Women Health Ltd
Cruxal reads every Gaudium IVF and Women Health Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.